Tirzepatide is a type of medication known as a GLP-1 receptor agonist, similar to semaglutide, also known as Ozempic
Maintenance programmes can generally mean applying a customised dose that leads to the right balance of food noise
Competing interests Ildiko Lingvay received research funding (paid to institution) from Novo Nordisk, Sanofi, Merck, Pfizer, Mylan and Boehringer Ingelheim
Supplementary information Source Data Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
The detailed comparison between these compounds helps researchers choose the right approach